Literature DB >> 6740537

Free and total plasma theophylline concentrations in chronic airflow obstruction.

P Ebden, D Leopold, A P Smith, D Buss, P A Routledge.   

Abstract

It has been suggested that the variability in clinical response between individuals at any given total plasma theophylline concentration may be related to interpatient variability in theophylline plasma protein binding. We therefore measured the plasma protein binding of theophylline in plasma from 39 outpatients with chronic airflow obstruction who were receiving long term oral theophylline treatment. The protein binding was measured at 37 degrees C and pH 7.4 by equilibrium dialysis. Total plasma theophylline concentration was measured by high performance liquid chromatography and the free concentration calculated by multiplying total concentration by the free (unbound) fraction. The total plasma theophylline concentration varied from 0.7 to 22.0 micrograms/ml, mean 10.6 (SD 5.3) micrograms/ml (3.9-121 mumol/l, mean 58.3 (29.2) mumol/l). The free fraction of theophylline varied only from 0.58 to 0.69 (mean 0.626 (0.024] microgram/ml and was not related to the total concentration (r = -0.236, n = 39, p greater than 0.05). There was a very close relationship between free and total plasma concentrations (r = 0.996, n = 39, p less than 0.001). It is concluded that there is little variability in plasma protein binding of theophylline in patients with chronic airflow obstruction. Other factors appear to be responsible for variability between individuals in the response to a given total plasma theophylline concentration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6740537      PMCID: PMC459801          DOI: 10.1136/thx.39.5.352

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  11 in total

1.  Effect of pH on the binding of theophylline to serum proteins.

Authors:  J J Vallner; W A Speir; R C Kolbeck; G N Harrison; E D Bransome
Journal:  Am Rev Respir Dis       Date:  1979-07

2.  Relationship between theophylline concentration in plasma and saliva of man.

Authors:  R Koysooko; E F Ellis; G Levy
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

3.  Micro-scale method for theophylline in body fluids by reversed-phase, high-pressure liquid chromatography.

Authors:  J J Orcutt; P P Kozak; S A Gillman; L H Cummins
Journal:  Clin Chem       Date:  1977-03       Impact factor: 8.327

4.  Rate immunonephelometric measurement of specific plasma proteins (an opportunity for control of analytical variance).

Authors:  C K Derry; C D Deaton; M D Gebott
Journal:  Ric Clin Lab       Date:  1980 Jan-Mar

5.  Binding of theophylline in human serum determined by ultrafiltration and equilibrium dialysis.

Authors:  O Brørs; G Sager; D Sandnes; S Jacobsen
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

6.  Factors influencing theophylline serum protein binding.

Authors:  L M Shaw; L Fields; R Mayock
Journal:  Clin Pharmacol Ther       Date:  1982-10       Impact factor: 6.875

7.  Determinants of the plasma protein binding of theophylline in health.

Authors:  D Buss; D Leopold; A P Smith; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

8.  Theophylline protein binding in humans.

Authors:  K J Simons; F E Simons; C J Briggs; L Lo
Journal:  J Pharm Sci       Date:  1979-02       Impact factor: 3.534

9.  Dose-dependency of theophylline clearance and protein binding.

Authors:  J A Fleetham; C E Bird; K Nakatsu; R D Wigle; P W Munt
Journal:  Thorax       Date:  1981-05       Impact factor: 9.139

10.  Theophylline serum protein binding in obstructive airways disease.

Authors:  L J Lesko; K J Tabor; B F Johnson
Journal:  Clin Pharmacol Ther       Date:  1981-06       Impact factor: 6.875

View more
  6 in total

1.  Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma.

Authors:  P E Williams; Y A Alwazir; P A Routledge; I A Campbell
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

2.  Protein binding of theophylline.

Authors:  D C Buss; P Ebden; S Baker; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

3.  Relationship between saliva and free and total plasma theophylline concentrations in patients with chronic airflow obstruction.

Authors:  P Ebden; D Leopold; D Buss; A P Smith; P A Routledge
Journal:  Thorax       Date:  1985-07       Impact factor: 9.139

4.  Variability of the serum protein binding of theophylline in patients with asthma and cystic fibrosis.

Authors:  J Blanchard; S Harvey; W J Morgan
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

5.  Determinants of free theophylline clearance in asthma.

Authors:  P E Williams; Y A Alwazir; M Littley; D C Buss; R John; I A Campbell; P A Routledge; J H Lazarus
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

6.  The ex vivo plasma protein binding of theophylline in renal disease.

Authors:  D Leopold; D Webb; D C Buss; R A Fifield; A P Smith; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.